The Board of Directors of the Atlanpole Biotherapies cluster elected on July 4, 2024 for 3 years
Board of Atlanpole Biotherapies
- President: Franck GRIMAUD – Valneva
- Executive vice-president: Jean-François BALDUCCHI – Atlanpole
- Vice-president Biotech: Eric Le Forestier – Naobios / Clean Biologics
- Vice-president Digital: Marwan Touati – Parean Biotechnologies
- Vice-presidente Clinical: Cécile Jaglin – CHU d’Angers / HUGO
- Vice-president Academic research: Férid Haddad – Arronax
- Vice-president International development: Franck Zal – Hemarina
- Vice-president Partnership relations: Louis-Marie Bachelot – Gliocure
- Treasurer: Odile Duvaux – Xenothera
- Secretary: Frédéric Ossant – CHU de Tours
Private College
- Louis-Marie Bachelot – GLIOCURE
- Jean-Marie Charpin – GENSENSOR
- Isabelle Dimier-Poisson – LOVALTECH
- Odile Duvaux – XENOTHERA
- Benoit Fouchaq – BIOFORTIS EUROPE
- Franck Grimaud – VALNEVA
- Ulrich Jarry – BIOTRIAL
- Eric Le Forestier – NAOBIOS / CLEAN BIOLOGICS
- Olivier Lépine – ALGOSOURCE
- Nicolas Poirier – OSE IMMUNOTHERAPEUTICS
- Marwan Touati – PAREAN BIOTECHNOLOGIES
- Franck Zal – HEMARINA
Higher education schools, research and care College
- Etienne Bendjebbar – CHU DE NANTES
- David Bigaud – UNIVERSITÉ D’ANGERS
- Férid Haddad – GIP ARRONAX
- Frédéric Jacquemin – NANTES UNIVERSITÉ
- Guillaume Mercusot – INSTITUT DE CANCÉROLOGIE DE L’OUEST
- Frédéric Ossant – CHU DE TOURS
- Charles Pineau – UNIVERSITÉ DE RENNES
- Nicolas Riffet-Vidal – CHU D’ANGERS
Economic development structures College
- Jean-François Balducchi – ATLANPOLE
- Nelly Besnard – BIOTECH SANTÉ BRETAGNE
- Emmanuel Lichou – ANGERS TECHNOPOLE
- Fabien Riolet – POLEPHARMA